This Nov 3rd, join us for the third edition of Business of Cannabis: New York at The Williamsburg Hotel. A day long leadership summit focused on retail, investment & policy across New York and North America. Tickets on-sale now – www.cannabisnewyork.live
Connecticut’s Department of Consumer Protection has released preliminary data showing combined sales for adult-use cannabis and medical cannabis totaled more than $25 million for the period from September 1, 2023 to September 30, 2023.
While August saw combined sales for adult-use cannabis and medical cannabis totaled nearly $25 million in August, September saw sales hit this $25m mark.
The data, collected through the state’s Seed-to-Sale Tracking System, revealed more than $14.3 million in adult-use sales in September, while medical cannabis saw almost $11 million in sales for the same period.
A total of 52% of sales for the month were for cannabis or flower, 30% were vapes and 11% of sales were edibles.
It also reveals that medical patients purchased 284,116 products, and adult-use consumers purchased 376,035 products, with the average product price for medical products being $38.21 in September and $38.37 for adult-use products.
The Department has emphasised that the preliminary data does not include taxes collected at the point of sale on adult-use transactions and is subject to further review by the department.
Transaction limits of 1/4 ounce of raw flower or the equivalent remain in effect for all adult-use purchases, while medical patients may purchase up to 5 ounces per month and are not subject to individual transaction limits.
The Department has confirmed it will make future data available at ct.gov/cannabis.
